About this event
Welcome to our educational webinar series, Precision Medicine in Practice – Turning Genomics into Action.
Episode 1: ESR1 Testing in Breast Cancer: Why, When and How?
How can ESR1 testing support treatment decisions in breast cancer? Join us for an educational webinar exploring its role in the management of hormone receptor-positive, HER2-negative advanced and metastatic breast cancer.
The session will address three practical questions:
Why test? Understand ESR1 mutations, their relationship with endocrine resistance, and their relevance to treatment selection.
When to test? Explore patient selection, testing at disease progression, and considerations for repeat testing.
How to test? Review liquid biopsy and tissue-based approaches, assay selection, and the interpretation of positive and negative results.
Through clinical insights and practical examples, we will discuss how to integrate ESR1 testing into clinical workflows and translate molecular findings into informed treatment discussions.
Who should attend? Oncologists, pathologists, molecular diagnostics professionals, Pharma and other healthcare professionals involved in breast cancer care.
Join the conversation and send your questions in advance to BD@actgenomics.com
SPEAKER & MODERATOR:
Rachel Liu, RPh, Senior Manager at Department of Medical Affairs
Rachel Liu is a Clinical Pharmacist and Medical Affairs professional at ACT Genomics, specializing in molecular diagnostics, precision oncology, and biomarker-driven strategies. She holds a MS in Clinical Epidemiology from Johns Hopkins University and a BS in Pharmacy from National Taiwan University, with prior experience at Eli Lilly and Taiwan’s Center for Drug Evaluation.
This session is moderated by Dr. Prerana Bhan, Director Global Business Development at ACT Genomics.
